Matt van de Rijn


Affiliation: Stanford University
Country: USA


  1. van de Rijn M, Rubin B. Gene expression studies on soft tissue tumors. Am J Pathol. 2002;161:1531-4 pubmed
  2. Guo X, Jo V, Mills A, Zhu S, Lee C, Espinosa I, et al. Clinically Relevant Molecular Subtypes in Leiomyosarcoma. Clin Cancer Res. 2015;21:3501-11 pubmed publisher
    ..The findings offer an opportunity for treating leiomyosarcoma in a subtype-specific targeted approach. ..
  3. van de Rijn M, Perou C, Tibshirani R, Haas P, Kallioniemi O, Kononen J, et al. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol. 2002;161:1991-6 pubmed
    ..Moreover, multivariate analysis showed that in node-negative breast carcinoma, expression of these cytokeratins was a prognostic factor independent of tumor size and tumor grade. ..